Jane S. Ricciuti, RPh, MS


December 27, 2002

In This Article

Diagnostic Hormones

(secretin) Injection

Manufacturer: ChiRhoClin, Inc.

Drug Approval Classification: Supplemental New Drug Application (Approval Date: 11/1/02)

New Indication: SecreFlo is now indicated for use in secretin stimulation testing for the stimulation of pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangio-pancreatography (ERCP).

Dosing: To facilitate the identification of the ampulla of Vater and during ERCP, the recommended dose is 0.2 mcg/kg body weight by intravenous injection over 1 minute.


SecreFlo (secretin) Injection labeling


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.